Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
Weinbergerova B, Mayer J, Kabut T, Hrabovsky S, Prochazkova J, Kral Z, Herout V, Pacasova R, Zdrazilova-Dubska L, Husa P, Bednar P, Ruzek D, Lengerova M.
Weinbergerova B, et al. Among authors: kabut t.
Hematol Oncol. 2021 Dec;39(5):715-720. doi: 10.1002/hon.2908. Epub 2021 Aug 16.
Hematol Oncol. 2021.
PMID: 34396566
Free PMC article.
Clinical Trial.
No abstract available.